NCT05692869View on ClinicalTrials.gov

A Study of Continuous Blood Pressure Monitoring in Healthy Participants

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

April 4, 2023

Study Completion Date

April 4, 2023

Conditions
Healthy
Interventions
DRUG

Propranolol

Administered orally.

DRUG

Pseudoephedrine

Administered orally.

DEVICE

ABPM and Wearable Novel Devices

ABPM and wearable novel devices including chest patch device, wrist device and smartwatch device worn throughout the trial.

OTHER

No Intervention

No intervention during this period (Control Period)

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY